|Articles|January 1, 2019
- BioPharm International-01-01-2019
- Volume 32
- Issue 1
BioPharm International, January 2019 Issue (PDF)
Click the title above to open the BioPharm International January 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 7 years ago
Internal and External Challenges to Biopharma in 2019almost 7 years ago
Matching Personal and Company Successalmost 7 years ago
Identifying Incentives to Adopt Advanced Manufacturingalmost 7 years ago
Modeling the Degradation of mAb Therapeuticsalmost 7 years ago
A Look at the Affinity Chromatography Landscapealmost 7 years ago
The Role of Automation in Cell-Line Developmentalmost 7 years ago
CDER Priorities for 2019: Opioids, Quality, Safety, and Innovationalmost 7 years ago
Global Inspection Harmonizationalmost 7 years ago
The Outlook for CMO Outsourcing in 2019Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
BioPharm Weekly News Roundup—Week of Oct. 13, 2025
2
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
3
Biotech Equipment Market to Approach $144B by 2030: Implications for Pharma R&D
4
CGT Innovations: The Three-Pronged Strategy for Industry Growth (Part 2)
5
